Generation and in vivo evaluation of IL10-treated dendritic cells in a nonhuman primate model of AAV-based gene transfer-Reference-Cited by-同舟云学术

Generation and in vivo evaluation of IL10-treated dendritic cells in a nonhuman primate model of AAV-based gene transfer

Published:2014 Issue: Volume:1 Page:14028
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Moreau Aurélie,Vandamme Céline,Segovia Mercedes,Devaux Marie,Guilbaud Mickaël,Tilly Gaëlle,Jaulin Nicolas,Le Duff Johanne,Cherel Yan,Deschamps Jack-Yves,Anegon Ignacio,Moullier Philippe,Cuturi Maria Cristina,Adjali Oumeya

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference56 articles.

1. Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector;Bohl;Blood,1998

2. Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy;Brantly;Proc Natl Acad Sci USA,2009

3. Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus;Favre;J Virol,2002

4. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector;Herzog;Nat Med,1999

5. Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer;Rivera;Blood,2005

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alleviating Recombinant Tissue Plasminogen Activator‐induced Hemorrhagic Transformation in Ischemic Stroke via Targeted Delivery of a Ferroptosis Inhibitor;Advanced Science;2024-04-22

2. Optimization of Interleukin‐10 incorporation for dendritic cells embedded in Poly(ethylene glycol) hydrogels;Journal of Biomedical Materials Research Part A;2024-04

3. A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients;Kidney International;2023-03

4. Challenges in tolerogenic dendritic cell therapy for autoimmune diseases: the route of administration;Immunotherapy Advances;2023-01-01

5. Regulatory Macrophages and Tolerogenic Dendritic Cells in Myeloid Regulatory Cell-Based Therapies;International Journal of Molecular Sciences;2021-07-26